Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
319.43
-0.99 (-0.31%)
At close: Jul 7, 2026, 4:00 PM EDT
319.43
0.00 (0.00%)
After-hours: Jul 7, 2026, 4:27 PM EDT
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or -30.88% compared to the previous year.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$5,839,915
Profits / Employee
$3,267,213
Market Cap
6.33B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| PTC Therapeutics | 991 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
LGND News
- 12 days ago - Ligand Announces Closing of Convertible Senior Notes Offering - GlobeNewsWire
- 14 days ago - Ligand prices upsized $625M convertible senior note offering - TheFly
- 14 days ago - Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering - GlobeNewsWire
- 15 days ago - Ligand files to sell $550M of convertible senior notes due 2031 - TheFly
- 15 days ago - Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031 - GlobeNewsWire
- 27 days ago - Ligand Announces 2026 Investor Day in New York City - GlobeNewsWire
- 5 weeks ago - Ligand price target raised to $266 from $263 at BofA - TheFly
- 5 weeks ago - Ligand to Participate in June Investor Conferences - GlobeNewsWire